# Axogen Corporation – FDA Inspection, Nov 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/axogen-corporation/6c574dbc-677c-4b2f-ae65-d7b0959d53d0
Source feed: FDA_Inspections

> FDA inspection 1072238 of Axogen Corporation, November 20, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1072238
- Company Name: Axogen Corporation
- Inspection Date: 2018-11-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1298590 - 2026-01-08
- [FDA Inspection 1275112 - 2025-06-19](https://www.keypedia.com/records/fda_inspections/axogen-corporation/f4ae9eb6-cb40-4c95-b2cc-c695779c02b9)
- FDA Inspection 1177562 - 2022-07-28
- FDA Inspection 946545 - 2015-10-13

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/abby-l-mozeke/ce4ecbbc-0108-483e-aff3-d5320e50114f)

Company: https://www.keypedia.com/companies/axogen-corporation/c1a3a1ba-57e3-4747-b670-8018198f0309

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
